Nektar | Bold Immune Science. Transformative Immune Health.
Nov 8, 2025 · Developing novel medicines that redefine treatment paradigms for autoimmune and inflammatory conditions. Learn about Nektar Therapeutics.
Press releases - Nektar Therapeutics
Oct 28, 2025 Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets Oct 22, 2025 Data from REZOLVE-AD …
Our Pipeline | Nektar Therapeutics
Our R&D pipeline leverages deep immunology insights to identify and develop novel therapeutics that target causal human biology and immune imbalances at their core.
Our Story | Nektar Therapeutics
Discover Nektar's story of scientific innovation, from foundational research to transformative therapies for immune-mediated diseases.
Careers at Nektar | Nektar Therapeutics
Explore biotechnology careers at Nektar Therapeutics. Join our innovative team developing life-changing therapies.
Scientific Approach | Nektar Therapeutics
Nektar targets regulatory T cells to resolve immune imbalances. Our scientific approach addresses root causes of immune-mediated disease.
Nektar Therapeutics Reports First Quarter 2025 Financial Results
May 8, 2025 · Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune …
Our Leadership | Nektar Therapeutics
Meet Nektar's expert executive leadership team and Board of Directors driving innovation in immune science.
Nektar Announces Definitive Agreement with Ampersand Capital …
Nov 4, 2024 · Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune …
For Patients | Nektar Therapeutics
At Nektar, we are dedicated to discovering novel therapies aimed at selectively targeting pathways within the immune system that play critical roles across a wide range of immune …